from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3437/-

LFCtreatmentdescriptionclass of inhibitor

-0.029

Amikacinug/mL Amikacintranslation

-1.473

Cap5-10ug/mL Capreomycintranslation

-1.425

Rox10-50 ug/mL Roxithromycintranslation

-1.566

SM2-5 ug/mL Streptomycintranslation

0.120

Tet5-10 ug/mL Tetracyclinetranslation

0.999

Rif0.2-5ug/mL Rifampicintranscription

-0.471

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.077

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.658

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.444

CPZ10-50 ug/mL Chlorpromazinerespiration

1.020

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.259

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.686

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.053

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.473

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.274

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.018

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.291

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.194

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.554

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.840

KCN5-20 ug/mL Potassium cyaniderespiration

-0.118

NaN30.2-2 mM Sodium aziderespiration

-1.245

Nigericin50 uM Nigericinrespiration

0.978

TRC10-150 ug/mL Triclosanrespiration

1.331

TRZ10-25 ug/mL Thioridazinerespiration

-0.971

Valinomycin0.5-10 uM Valinomycinrespiration

-3.231

ZnSO42 mM ZnSO4respiration

-0.544

menadione6-10 ug/mL Menadionerespiration

0.665

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.596

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.213

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.151

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.229

NRP_1Non-replicating persistence stage 1dosRassociated

-0.757

Amp0.2mg/mL AmpicillincellWall

-0.262

Cephalexin20-100 ug/mL CephalexincellWall

-0.387

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.720

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.431

EMB10-20 ug/mL EthambutolcellWall

-0.627

Eta12-40 ug/mL EthionamidecellWall

-0.724

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.264

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.866

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.421

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.013

BZA0.12 mg/mL BenzamidearomaticAmides

-0.108

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.444

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.727

H2O24 mM hydrogen peroxideDNAdamaging

-0.592

Levo10 ug/mL LevofloxacinDNAdamaging

-0.097

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.319

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.053

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.001

UVUV-irradiationDNAdamaging

1.171

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.451

Antimycin12.5-50 ug/mL Antimycin A?

-1.016

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.003

PA_110-50 ug/mL Antitubercular compound PA-1?

0.208

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.792

PA8240.2-2 ug/mL PA-824?

0.750

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.385

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.090

Verapamil50 uM Verapamil?

-1.139

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.898

methoxatin10-20 ug/mL Methoxatin?